ENO1 and hepatocellular carcinoma: Likewise, ENO1 (alpha-enolase), as an RNA-binding protein, abrogates the expression of iron regulatory protein 1 (IRP1) and mitochondrial iron-induced ferroptosis, indicating an underlying therapeutic target for HCC (Zhang T. et al., 2022).